About Tolera Therapeutics
Tolera Therapeutics is a biotechnology company developing novel therapies for patients and physicians and providing more effective and safer clinical solutions for immune modulation and related therapies. The company has recently completed its Series A round, and intends to commercialize its lead therapeutic agent TOL101 (T-cell modulation) for acute rejection in kidney transplantation, followed by further development and commercialization of autoimmune and oncology applications.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in Spanish can be found here.
- Industry : Pharma
